Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Insulin Resistance in Patients With Major Depression
Trial ID or NCT#
NCT01106313
Status
Purpose
The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.
Official Title
Insulin Resistance in Patients With Major Depression
Eligibility Criteria
Ages Eligible for Study: 20 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Natalie L. Rasgon
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center, Emerita
Contact us to find out if this trial is right for you.
CONTACT
Norma Costello
(650) 736-2182
View on ClinicalTrials.gov
About this Clinical Trial
Insulin Resistance in Patients With Major Depression
Your Message Will Go To
Norma Costello6507362182